‘Age to buy cigarettes should rise annually’


Share post:

The age at which people can buy tobacco in England should rise by one each year until it becomes a “smoke-free” society, a government-commissioned review recommended on Thursday (June 9).

The minimum age today is 18. But the review by Javed Khan, former head of children’s charity Barnardo’s, advised raising it annually until eventually no one can buy tobacco products.

His review recommends 15 interventions to help the government meet its national target to be smoke-free by 2030, including the promotion of vaping to help smokers quit.

“Without immediate and sustained action, England will miss the smoke-free target by many years and most likely decades,” said Khan.

“A smoke-free society should be a social norm –- but to achieve this, we must do more to stop people taking up smoking, help those who already smoke and support those who are disproportionately impacted by smoking.”

Almost six million people in England smoke, and it is the single biggest cause of preventable illness and death.

Around one in four deaths from all cancers are linked to smoking, according to official figures.

Sanjay Agrawal, chair of the Royal College of Physicians’ tobacco group, told BBC radio that there had been a 30 percent reduction in smoking in the 16-18 age group since the age limit was raised from 16 in 2007.

New Zealand unveiled a similar plan in 2021, with a year-on-year rise in the smoking age limit set to come into force in 2027.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...